Friday, February 25, 2022

Google Alert - finance

Google
finance
As-it-happens update February 25, 2022
NEWS
AJMC.com Managed Markets Network
Jardiance (empagliflozin) received approval from the FDA for a new indication to treat heart failure in a broader range of patients, including those with preserved ejection fraction. This story has been updated. The FDA today approved the use of Eli ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

No comments:

Post a Comment